To the Editor On behalf of 3 professional associations representing medical writers (MWs)—the American Medical Writers Association, the European Medical Writers Association, and the International Society for Medical Publication Professionals—we contest the remarks made about MWs by Del Paggio et al1 in their recent cohort study published in JAMA Oncology.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Schindler TM, Marchington JM, Flores GV. Randomized Clinical Trials in the Era of Precision Oncology—The Role of End Points, Industry Funding, and Medical Writing Integrity. JAMA Oncol. 2021;7(10):1578–1579. doi:10.1001/jamaoncol.2021.3341
Monkeypox Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.